These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 6541429)

  • 61. Pharmacologic reversion of persistent atrial fibrillation with amiodarone predicts long-term sinus rhythm maintenance.
    Galperín J; Elizari MV; Chiale PA; Molina RT; Ledesma R; Scapín AO; Blanco MV; Bonato R; Lago M;
    J Cardiovasc Pharmacol Ther; 2003 Sep; 8(3):179-86. PubMed ID: 14506542
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Amiodarone in refractory life-threatening ventricular arrhythmias.
    Nademanee K; Singh BN; Hendrickson J; Intarachot V; Lopez B; Feld G; Cannom DS; Weiss JL
    Ann Intern Med; 1983 May; 98(5 Pt 1):577-84. PubMed ID: 6846970
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Amiodarone for refractory atrial fibrillation.
    Gold RL; Haffajee CI; Charos G; Sloan K; Baker S; Alpert JS
    Am J Cardiol; 1986 Jan; 57(1):124-7. PubMed ID: 3942054
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Prognostic value of non-sustained ventricular tachycardia and the potential role of amiodarone treatment in hypertrophic cardiomyopathy: assessment in an unselected non-referral based patient population.
    Cecchi F; Olivotto I; Montereggi A; Squillatini G; Dolara A; Maron BJ
    Heart; 1998 Apr; 79(4):331-6. PubMed ID: 9616338
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Suppression of arrhythmias within hours after a single oral dose of amiodarone and relation to plasma and myocardial concentrations.
    Escoubet B; Coumel P; Poirier JM; Maison-Blanche P; Jaillon P; Leclercq JF; Menasche P; Cheymol G; Piwnica A; Lagier G
    Am J Cardiol; 1985 Mar; 55(6):696-702. PubMed ID: 3976511
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Management of arrhythmias in hypertrophic cardiomyopathy.
    Stewart JT; McKenna WJ
    Cardiovasc Drugs Ther; 1994 Feb; 8(1):95-9. PubMed ID: 8086333
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Effect of amiodarone on left ventricular ejection and filling in hypertrophic cardiomyopathy as assessed by radionuclide angiography.
    Sugrue DD; Dickie S; Myers MJ; Lavender JP; McKenna WJ
    Am J Cardiol; 1984 Nov; 54(8):1054-8. PubMed ID: 6541867
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Safety and efficacy of amiodarone. The low-dose perspective.
    Kowey PR; Friehling TD; Marinchak RA; Sulpizi AM; Stohler JL
    Chest; 1988 Jan; 93(1):54-9. PubMed ID: 3335168
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Nonsustained ventricular tachycardia as a predictor for sudden death in patients with idiopathic dilated cardiomyopathy. The role of amiodarone treatment.
    Castelli G; Ciaccheri M; Cecchi F; Troiani V; Nannini M; Marconi P; Olivotto J; Montereggi A; Dolara A
    G Ital Cardiol; 1999 May; 29(5):514-23. PubMed ID: 10367218
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Amiodarone and the cardiomyopathies.
    McKenna WJ
    Br J Clin Pract Suppl; 1986 Apr; 44():3-10. PubMed ID: 3089258
    [No Abstract]   [Full Text] [Related]  

  • 71. QT prolongation and the antiarrhythmic efficacy of amiodarone.
    Torres V; Tepper D; Flowers D; Wynn J; Lam S; Keefe D; Miura DS; Somberg JC
    J Am Coll Cardiol; 1986 Jan; 7(1):142-7. PubMed ID: 3941202
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Amiodarone: clinical efficacy and toxicity in 96 patients with recurrent, drug-refractory arrhythmias.
    Fogoros RN; Anderson KP; Winkle RA; Swerdlow CD; Mason JW
    Circulation; 1983 Jul; 68(1):88-94. PubMed ID: 6851057
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Long term efficacy and toxicity of amiodarone in the treatment of refractory cardiac arrhythmias.
    Primeau R; Agha A; Giorgi C; Shenasa M; Nadeau R
    Can J Cardiol; 1989 Mar; 5(2):98-104. PubMed ID: 2706579
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Clinical value of cordarone as an antiarrhythmic agent.
    Piwowarska W; Sniezek-Maciejewska M
    Cor Vasa; 1987; 29(4):269-77. PubMed ID: 2445525
    [TBL] [Abstract][Full Text] [Related]  

  • 75. [Treatment of malignant ventricular tachyarrhythmia with amiodarone: comparison of empirical administration and administration guided by Holter or ventricular stimulation. Results of the parallel test].
    Raviele A; Di Pede F; Gasparini G; Zanocco A; Delise P; Bonso A; D'Este D; Piccolo E
    G Ital Cardiol; 1991 Mar; 21(3):259-69. PubMed ID: 1894120
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Sustained arrhythmias in hypertrophic obstructive cardiomyopathy.
    Kowey PR; Eisenberg R; Engel TR
    N Engl J Med; 1984 Jun; 310(24):1566-9. PubMed ID: 6539421
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Relation between amiodarone and desethylamiodarone plasma concentrations and electrophysiologic effects, efficacy and toxicity.
    Greenberg ML; Lerman BB; Shipe JR; Kaiser DL; DiMarco JP
    J Am Coll Cardiol; 1987 May; 9(5):1148-55. PubMed ID: 3571754
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Amiodarone in patients with previous drug-mediated torsade de pointes. Long-term safety and efficacy.
    Mattioni TA; Zheutlin TA; Sarmiento JJ; Parker M; Lesch M; Kehoe RF
    Ann Intern Med; 1989 Oct; 111(7):574-80. PubMed ID: 2774388
    [TBL] [Abstract][Full Text] [Related]  

  • 79. [Ambulatory ECG in cardiomyopathies].
    Mestroni L; Miani D; Neri R; Di Lenarda A; Camerini F
    G Ital Cardiol; 1987 Dec; 17(12):1139-44. PubMed ID: 3503812
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Control of recurrent supraventricular tachycardia with amiodarone hydrochloride.
    Swan JH; Chisholm AW
    Can Med Assoc J; 1976 Jan; 114(1):43-4. PubMed ID: 943223
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.